Ovace

Product NDC
0178-0696
Requested package NDC
0178-0696-01
11-digit product format
001780696
Labeler code
0178
Product ID
0178-0696_b8536ed0-0f0d-4a71-e053-2995a90a655d
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
SODIUM SULFACETAMIDE
Dosage form
AEROSOL, FOAM
Route
TOPICAL
Labeler
Mission Pharmacal Company
Marketing category
UNAPPROVED DRUG OTHER
Marketing start
2010-07-15
Marketing end
0000-00-00
Substance
SULFACETAMIDE SODIUM
Active strength
98 mg/g
Pharmacologic classes
Sulfonamide Antibacterial [EPC],Sulfonamides [CS]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage0178-06960178-0696-01DDiscontinued by firm2026-09-14

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source dateSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-312ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-100efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09557ba5c1ecfa…9c80585c8c6e…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0178-0696-01GM - Gram0178-06969a809e0e-b6e2-4d6f-b6c7-1effdfae053b12015-07-20

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
SULFACETAMIDE SODIUMACTIVE INGREDIENT4NRT660KJQOVACE PLUS (SODIUM SULFACETAMIDE) AEROSOL, FOAM [MISSION PHARMACAL COMPANY]1
SULFACETAMIDEACTIVE MOIETY4965G3J0F5OVACE PLUS (SODIUM SULFACETAMIDE) AEROSOL, FOAM [MISSION PHARMACAL COMPANY]1
1,1,2,2-TETRAFLUOROETHANEINACTIVE INGREDIENTX2I96B6OVWOVACE PLUS (SODIUM SULFACETAMIDE) AEROSOL, FOAM [MISSION PHARMACAL COMPANY]1
BENZYL ALCOHOLINACTIVE INGREDIENTLKG8494WBHOVACE PLUS (SODIUM SULFACETAMIDE) AEROSOL, FOAM [MISSION PHARMACAL COMPANY]1
CETYL ALCOHOLINACTIVE INGREDIENT936JST6JCNOVACE PLUS (SODIUM SULFACETAMIDE) AEROSOL, FOAM [MISSION PHARMACAL COMPANY]1
GLYCERYL MONOSTEARATEINACTIVE INGREDIENT230OU9XXE4OVACE PLUS (SODIUM SULFACETAMIDE) AEROSOL, FOAM [MISSION PHARMACAL COMPANY]1
MAGNESIUM ALUMINUM SILICATEINACTIVE INGREDIENT6M3P64V0NCOVACE PLUS (SODIUM SULFACETAMIDE) AEROSOL, FOAM [MISSION PHARMACAL COMPANY]1
MAGNESIUM SILICATEINACTIVE INGREDIENT9B9691B2N9OVACE PLUS (SODIUM SULFACETAMIDE) AEROSOL, FOAM [MISSION PHARMACAL COMPANY]1
PEG-100 STEARATEINACTIVE INGREDIENTYD01N1999ROVACE PLUS (SODIUM SULFACETAMIDE) AEROSOL, FOAM [MISSION PHARMACAL COMPANY]1
PHENOXYETHANOLINACTIVE INGREDIENTHIE492ZZ3TOVACE PLUS (SODIUM SULFACETAMIDE) AEROSOL, FOAM [MISSION PHARMACAL COMPANY]1
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3OVACE PLUS (SODIUM SULFACETAMIDE) AEROSOL, FOAM [MISSION PHARMACAL COMPANY]1
SODIUM LAURYL SULFATEINACTIVE INGREDIENT368GB5141JOVACE PLUS (SODIUM SULFACETAMIDE) AEROSOL, FOAM [MISSION PHARMACAL COMPANY]1
SODIUM THIOSULFATEINACTIVE INGREDIENTHX1032V43MOVACE PLUS (SODIUM SULFACETAMIDE) AEROSOL, FOAM [MISSION PHARMACAL COMPANY]1
STEARYL ALCOHOLINACTIVE INGREDIENT2KR89I4H1YOVACE PLUS (SODIUM SULFACETAMIDE) AEROSOL, FOAM [MISSION PHARMACAL COMPANY]1
WATERINACTIVE INGREDIENT059QF0KO0ROVACE PLUS (SODIUM SULFACETAMIDE) AEROSOL, FOAM [MISSION PHARMACAL COMPANY]1
XANTHAN GUMINACTIVE INGREDIENTTTV12P4NEEOVACE PLUS (SODIUM SULFACETAMIDE) AEROSOL, FOAM [MISSION PHARMACAL COMPANY]1

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
0178-0696-0100178069601100 g in 1 CANISTER (0178-0696-01) 100 g2010-07-150000-00-00NoNoCurrent